Abstract
Teng C-F, Wang T, Wu T-H, et al. Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model. Therapeutic Advances in Medical Oncology (2020). 12: 1–20. https://doi.org/10.1177/1758835920922034
While processing this paper, the affiliations for the authors were listed incorrectly. The correct affiliations are as given below. These have been corrected in the online version of the article.
Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu, Jia-Hui Lin, Fu-Ying Shih, Woei-Cherng Shyu and Long-Bin Jeng
Graduate Institute of Biomedical Sciences, China Medical University, No.91, Hsueh-Shih Rd., Northern Dist., Taichung City 404, Taiwan
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan
Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
Graduate Institute of Biomedical Sciences, China Medical University, No.91, Hsueh-Shih Rd., Northern Dist., Taichung City 404, Taiwan
Department of Occupational Therapy, Asia University, Taichung, Taiwan
Department of Neurology, China Medical University Hospital, Taichung, Taiwan
Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan
Organ Transplantation Center, China Medical University Hospital, No.2, Yude Rd., Northern Dist., Taichung City 404, Taiwan
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan
Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
Program for Biotech Pharmaceutical Industry, School of Pharmacy, China Medical University, Taichung, Taiwan